Gopal Grandhige, MD, FACS, Board-Certified Surgeon Last Reviewed: March 16, 2026 BPC-157 typically begins working within the first one to two weeks, with most patients noticing subtle improvements such as reduced soreness, better digestion, and decreased inflammation during this early phase
You can book online or contact our Southwest Sacramento clinic directly by phone or text
Key Research Applications Skin & collagen research: GHK-Cu and BPC-157 together support studies on collagen type I/III upregulation, elastin production, and dermal matrix integrity
6 B12 loading shots, then 6 month wait
Selank (10mg Vial) Dosage Protocol Anxiolytic / nootropic heptapeptide (tuftsin analog) research/educational dosing reference
The safety profile of DSIP is remarkable: 97% tolerability in clinical trials, and no lethal dose (LD50) has ever been determined in animals